Xerox Corporation Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash Flows from Operating Activities
Net Income (Loss)	$ 60	$ (444)
Adjustments required to reconcile Net income (loss) to cash flows provided by (used in) operating activities
Depreciation and amortization	189	205
Provisions	37	48
Net gain on sales of businesses and assets	(37)	(17)
PARC donation	132	0
Stock-based compensation	40	63
Goodwill impairment	0	412
Restructuring and asset impairment charges	25	44
Payments for restructurings	(23)	(38)
Non-service retirement-related costs	14	(18)
Contributions to retirement plans	(75)	(106)
Increase in accounts receivable and billed portion of finance receivables	(47)	(48)
Decrease (increase) in inventories	50	(136)
Increase in equipment on operating leases	(109)	(74)
Decrease (increase) in finance receivables	490	(10)
(Increase) decrease in other current and long-term assets	(8)	36
(Decrease) increase in accounts payable	(290)	198
Increase in accrued compensation	16	29
Decrease in other current and long-term liabilities	(159)	(73)
Net change in income tax assets and liabilities	(24)	(81)
Net change in derivative assets and liabilities	16	(10)
Other operating, net	0	(7)
Net cash provided by (used in) operating activities	297	(27)
Cash Flows from Investing Activities
Cost of additions to land, buildings, equipment and software	(27)	(39)
Proceeds from sales of businesses and assets	40	49
Acquisitions, net of cash acquired	(7)	(93)
Other investing, net	(3)	(12)
Net cash provided by (used in) investing activities	3	(95)
Cash Flows from Financing Activities
Net proceeds from short-term debt	220	0
Proceeds from issuance of long-term debt	646	754
Payments on long-term debt	(997)	(1,259)
Other financing, net	(13)	(6)
Net cash used in financing activities	(819)	(755)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(3)	(31)
Decrease in cash, cash equivalents and restricted cash	(522)	(908)
Cash, cash equivalents and restricted cash at beginning of period	1,139	1,909
Cash, Cash Equivalents and Restricted Cash at End of Period	617	1,001
XEROX CORPORATION
Cash Flows from Operating Activities
Net Income (Loss)	60	(444)
Adjustments required to reconcile Net income (loss) to cash flows provided by (used in) operating activities
Depreciation and amortization	189	205
Provisions	37	48
Net gain on sales of businesses and assets	(37)	(17)
PARC donation	132	0
Stock-based compensation	40	63
Goodwill impairment	0	412
Restructuring and asset impairment charges	25	44
Payments for restructurings	(23)	(38)
Non-service retirement-related costs	14	(18)
Contributions to retirement plans	(75)	(106)
Increase in accounts receivable and billed portion of finance receivables	(47)	(48)
Decrease (increase) in inventories	50	(136)
Increase in equipment on operating leases	(109)	(74)
Decrease (increase) in finance receivables	490	(10)
(Increase) decrease in other current and long-term assets	(8)	36
(Decrease) increase in accounts payable	(290)	198
Increase in accrued compensation	16	29
Decrease in other current and long-term liabilities	(159)	(73)
Net change in income tax assets and liabilities	(24)	(81)
Net change in derivative assets and liabilities	16	(10)
Other operating, net	0	(7)
Net cash provided by (used in) operating activities	297	(27)
Cash Flows from Investing Activities
Cost of additions to land, buildings, equipment and software	(27)	(39)
Proceeds from sales of businesses and assets	40	49
Acquisitions, net of cash acquired	(7)	(93)
Other investing, net	0	1
Net cash provided by (used in) investing activities	6	(82)
Cash Flows from Financing Activities
Net proceeds from short-term debt	220	0
Proceeds from issuance of long-term debt	646	754
Payments on long-term debt	(997)	(1,259)
Distributions to parent	(685)	(267)
Other financing, net	(6)	4
Net cash used in financing activities	(822)	(768)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(3)	(31)
Decrease in cash, cash equivalents and restricted cash	(522)	(908)
Cash, cash equivalents and restricted cash at beginning of period	1,139	1,909
Cash, Cash Equivalents and Restricted Cash at End of Period	$ 617	$ 1,001